Lorvas SR 1.5 Tablet
Indapamide
1.5mg
Torrent Pharmaceuticals Ltd.
| Pack size | 100's |
|---|---|
| Dispensing mode | |
| Source | |
| Agent | |
| Retail Price | 12.26 NPR |
Available as:
Indications
Lorvas SR 1.5 Tablet is used for:
Hypertension, Congestive heart failure
Adult Dose
Oral
Hypertension
Adult: 1.25-2.5 mg once daily, alone or in conjunction with other antihypertensives.
Oedema
Adult: 2.5 mg once daily increased to 5 mg daily after 1 wk if needed.
Child Dose
Safety & efficacy not established
Renal Dose
Administration
Should be taken with food.
Contra Indications
Anuria, severe hepatic impairment.
Precautions
Pregnancy, lactation, elderly, renal impairment, fluid or electrolyte imbalance, hyperuricaemia, DM, lupus erythematosus.
Lactation: not known if excreted into breast milk, avoid
Pregnancy-Lactation
Interactions
Additive effect with other antihypertensive agents and diuretics. Increased chance of hypokalaemia with corticosteroids, corticotropin and amphotericin.
Potentially Fatal: Increased risk of lithium toxicity. Hypokalaemia enhances digitalis toxicity with cardiac gycosides.
Adverse Effects
Side effects of Indapamide :
1-10%
Hypotension,Palpation,Flushing,Dizziness,Lightheadedness,Vertigo,Headache,Weakness,Restlessness,Drowsiness,Fatigue,Lethargy,Malaise,Anorexia,Nausea/vomiting,Nocturia,Polyuria,Blurred vision,Rhinnorhea,Electrolyte abnormalities,Pruritus,Rash
<1%
Cutaneous vasculitis,Glycosuria,Pancreatitis
Mechanism of Action
Indapamide enhances excretion of sodium, chloride and water by interfering with the transport of sodium ions across the renal tubular epithelium.
Note
Lorvas SR 1.5 1.5mg Tablet manufactured by Torrent Pharmaceuticals Ltd.. Its generic name is Indapamide. Lorvas SR 1.5 is availble in Nepal.
Farmaco Nepal drug index information on Lorvas SR 1.5 Tablet is not intended for diagnosis, medical advice or treatment; neither intended to be a substitute for the exercise of professional judgment.